Your SlideShare is downloading. ×
Professor Commentary Module II (Part 2)
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Professor Commentary Module II (Part 2)

381
views

Published on

Part 2 of the commentary for Module 6, Qualitative Research, is the PowerPoint for Chapter 16 of the text.

Part 2 of the commentary for Module 6, Qualitative Research, is the PowerPoint for Chapter 16 of the text.

Published in: Economy & Finance, Technology

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
381
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Chapter 6 Drug Therapy in the 21st Century
  • 2. Changes in Health Care in the 21 st Century
    • Access to medical and pharmacologic information is available from many sources
    • Consumers are taking steps to demand specific treatments and considerations
    • Alternative therapies are being offered and advertised
    • Financial pressures are leading to early discharge
    • Patient teaching and home care provisions are vital
  • 3. Federal Guidelines—Drug Advertising
    • When the advertisement states the indication, it must also include:
      • Contraindications
      • Adverse effects
      • Precautions
  • 4. Internet Sources for Drug Information
    • Pharmaceutical company information sites
    • Chat rooms with other people who are taking the drug
    • Online pharmacies
    • Lists of government regulations
    • Research reports about the drug and its effectiveness
  • 5. Internet Site Evaluation
    • Navigation
      • Is the site easy to access and navigate or confusing?
    • Contributor
      • Who prepared the site and what are his qualifications? Is it reviewed, or is it purely commercial?
    • Dates
      • Is the site updated frequently?
    • Accuracy/reliability
      • Is the information supported by other sites, accurate, and in agreement with other sources you have reviewed? Are other links listed?
  • 6. Problems Associated With OTC Medications
    • Can mask the signs and symptoms of disease
    • Can interact with prescription drugs
    • Can be taken in greater than the recommended dose, leading to toxicity
  • 7. Over-the-Counter Drugs
    • Drugs that were “grandfathered” in
    • Former prescription drugs that have been tested and found to be safe for the general public if used as directed
  • 8. Alternative Therapy Drawbacks
    • The active ingredient has not been tested by the FDA
    • Incidental ingredients are unknown
    • Patients do not always mention these therapies to their health care providers
    • Drug–alternative therapy interactions may occur
  • 9. Controls for Alternative Therapy
    • Herbal medications and alternative therapies are not controlled or tested by the FDA
    • Advertisement for these drugs is not restricted because they are considered dietary supplements
    • No regulation by any industry
  • 10. Off-Label Medications
    • Definition
      • The use of a drug for an indication that is not approved by the FDA
    • Occurrence
      • Commonly takes place in groups of patients for whom there is little premarketing testing
      • Used with pediatric and geriatric populations
  • 11. Health Care in Crisis
    • Skyrocketing cost of medical care and drugs
    • Huge research and equipment requirements to meet consumer demands
    • Rising cost of health insurance
    • Earlier discharge from hospitals
  • 12. Measures to Protect the Public From Bioterrorism
    • Emergency preparedness at all levels of the government
  • 13. Treatments for Exposure to Biological/Chemical Weapons
    • Insert table 6.3